The growth of the global lung injury market is majorly driven by rise in prevalence of lung-related diseases and increase in geriatric population.

WILMINGTON, DELAWARE, UNITED STATES, May 3, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Lung Injury Market by Application, Technology, and end user: global opportunity analysis and industry forecast, 2021–2030," the global lung injury market size was valued at $1.5 billion in 2020 and is projected to reach $2.4 billion by 2030 registering a CAGR of 4.20% from 2021 to 2030.

𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 @ https://www.alliedmarketresearch.com/request-sample/A13080

Rise in prevalence of lung-related diseases and increase in geriatric population act as the key driving forces of the global lung injury market. Furthermore, rise in awareness related to treatment of ALI or acute respiratory distress syndrome (ARDS) is anticipated to augment the growth of the global lung injury market. However, complications associated with the use of therapies and low adoption rate due to these complications act as the major deterrents of the market. Conversely, pipeline drugs for ALI, which are in the last of clinical trial, are expected to offer potential growth opportunities for the market during the forecast period.

Acute lung injury represents the most severe form of the viral infection sustained by COVID‐19. Incidence and severity of acute lung injury are a key determining factor of the prognosis of patients with COVID‐19 infection. Around 30% of patients with COVID‐19 infection in the ICU diagnosed with severe lung edema, dyspnea, hypoxemia, or even acute respiratory distress syndrome. Hence, the overall impact of COVID-19 pandemic remained positive, as COVID-19 has direct relation with acute lung injury, and hence boosted the use of therapies and devices, which is likely to drive the growth of the lung injury market.

The global lung injury market is segmented into therapy, end user, and region. Depending on therapy, the market is bifurcated into medication and device. The medication segment is further categorized into pharmacotherapy, fluid management, and inhaled nitric oxide. Moreover, the devices is subdivided into mechanical ventilation and adjunctive procedures devices.

On the basis of injury type, the market is classified into direct injury and indirect injury. By end user, it is fragmented into hospitals & clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of therapy, the medication segment was the major shareholder 2020, as various therapies were used as supportive treatment for lung injury.

Depending on injury type, the direct injury acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to rise in incidence of pulmonary infections worldwide.

Asia-Pacific accounted for the largest share of the global lung injury market in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to the presence of large population base, increase in awareness associated with lung injury treatment, and rise in healthcare expenditure. Furthermore, surge in incidence of pulmonary infections in the region, which require the use of medications and devices for treatment of lung injury drives the growth of the market in this region.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐃𝐚𝐭𝐚 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 @ https://www.alliedmarketresearch.com/purchase-enquiry/A13080

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐑𝐞𝐯𝐢𝐞𝐰

Lung injury is a severe condition caused by acute hypoxemic respiratory failure. It is a major reason of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Furthermore, this condition is marked by symptoms such as severe shortness of breath, confusion, low blood pressure, and extreme tiredness.

Furthermore, increase in the prevalence of lung-related diseases, surge in geriatric population, rise in awareness associated with the treatment of lung injury, and improvement of healthcare infrastructure in emerging economies are the major factors that augment the growth of the lung injury market. However, controversial outcomes with the use of medications and devices in the management and treatment of ALI or acute respiratory distress syndrome (ARDS) limit the demand for these products, thereby affecting the growth of the market. For instance, although mechanical ventilation is often a life-saving intervention, it exhibits potential complications, including pneumothorax, alveolar damage, ventilator-associated pneumonia, airway injury, and ventilator-associated tracheobronchitis.

𝐅𝐫𝐞𝐪𝐮𝐞𝐧𝐭𝐥𝐲 𝐀𝐬𝐤𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬?

Q1. Which is the most influencing segment growing in the Lung Injury market report?
Q2. What are the key trends in the Lung Injury market report?
Q3. What is the total market value of Lung Injury market report ?
Q4. Which are the top companies hold the market share in Lung Injury market ?
Q5. What are the market values / growth % of emerging countries?
Q6. What would be forecast period in the market report?
Q7. What is the market value of Lung Injury market in 2021?
Q8. Which is base year calculated in the Lung Injury market report?

𝐌𝐚𝐤𝐞 𝐚 𝐃𝐢𝐫𝐞𝐜𝐭 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 @ https://www.alliedmarketresearch.com/lung-injury-market/purchase-options

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other